Original Articles

Alexiades, M.R. and Cepko, C.L. Quantitative analysis of proliferation and cell cycle length during development of the rat retina. Developmental Dynamics 1996; 205: 293-307.

 

Cepko, C.L., Austin, C.P., Yang, X., Alexiades, M.R. and Ezzedine, D. Cell fate determination in the vertebrate retina. Proc Natl Acad Sci. USA 1996 Jan 23; 93: 589-595.

 

Alexiades, M.R. and Cepko, C.L. Subsets of retinal progenitors display temporally regulated and distinct biases in the fates of their progeny. Development 1997 Mar; 124: 1119-1131.

 

Alexiades-Armenakas, M.R. and Soter, N.A. Selected pearls for the NYU clinical conferences: Urticaria pigmentosa. J. Clin. Dermatol. 2(4), 32-40, 1999.

 

Alexiades-Armenakas, M. Tumid lupus erythematosus. Dermatol Online J. 2001 Dec; 7 (2): 14.

 

Alexiades-Armenakas, M. Juvenile rheumatoid arthritis (juvenile chronic arthritis). Dermatol Online J. 2001 Dec; 7 (2): 19.

 

Mafong, E.A., Friedman, P.M., Kauvar, A.N.B., Bernstein, L.J., Alexiades-Armenakas, M.R. and Geronemus, R.G. Treatment of inverse psoriasis with the 308 nm excimer laser. Derm Surg 2002 Jun; 28(6): 530, 2002.

 

Alexiades-Armenakas, M.R., Baldassano, M., Bince, B., Werth, V., Bystryn, J.-C., Kamino, H., Soter, N.A., and Franks, A., Jr. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum 2003 Aug 15; 49 (4): 494-500.

 

Chen J.Z.S., Alexiades-Armenakas, M.R., Bernstein, L.J., Jacobson, L.G., Friedman, P.M., and Geronemus, R.G.:Two randomized, double-blind, placebo-controlled studies evaluating the S-CAINE™ PEEL for induction of local anesthesia prior to LP Nd:YAG laser therapy for leg veins.  Derm Surg 2003 Oct; 29 (10): 1012-8.

 

Alexiades-Armenakas, M.R. and Geronemus, R.G. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol  2003 Oct; 139 (10): 1313-20.

 

Jacobson, L.G., Alexiades-Armenakas, M.R., Bernstein, L., and Geronemus, R.G. 2003. Treatment of nasolabial folds and jowls with a non-invasive radiofrequency device. Arch Dermatol 2003 Oct; 139(10): 1313-20.

 

Alexiades-Armenakas, M.R., Bernstein, L J., Friedman, P.M. and Geronemus, R.G. The safety and efficacy of the 308 nm excimer laser for pigment correction of hypopigmented scars and striae alba. Arch Dermatol  2004 Aug; 140 (8): 955-60.

 

Alexiades-Armenakas, M.R. and Geronemus, R.G. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol 2004 Sept-Oct; 3(5): 548-552.

 

Alexiades-Armenakas, M.R. Laser-mediated photodynamic therapy of lichen sclerosus. J Drugs Dermatol Nov-Dec 2004; 3(6 Suppl): S25-7.

 

Sadick, N., Alexiades-Armenakas, M., Bitter, P., Hruza, G., Mulholland, S. Enhanced full-face skin rejuvenation using synchronous intense pulsed optical and conducted, bipolar radiofrequency energy (ELOS): introducing selective radiophotothermolysis. J Drugs Dermatol 2005 Mar-April 4(2): 181-6.

 

Alexiades-Armenakas, M. Laser and light technology and phototherapy.
J Drugs Dermatol 2005 Jul-Aug;4(4):514-5.

 

Alexiades-Armenakas, M. Intense pulsed light-mediated photodynamic therapy.
J Drugs Dermatol 2005 Sep-Oct;4(5):657-8.

 

Alexiades-Armenakas, M.R. Laser-mediated photodynamic therapy. Clinics in Dermatology 2006; 24(1): 16-25.

 

Alexiades-Armenakas, M. R. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.  J Drugs Dermatol 2006 Jan; 5(1): 1-11.

 

Alexiades-Armenakas, M. New and emerging treatments in laser and light.
J Drugs Dermatol 2006 Jan; 5(1): 85.

 

Alexiades-Armenakas M.R. Laser skin tightening: non-surgical alternative to the face-lift. J Drugs Dermatol 2006 Mar; 5(3): 295-6.

 

Alexiades-Armenakas M.R. Update on soft tissue augmentation. J Drugs Dermatol 2006 May; 5(5).

 

Alexiades-Armenakas M.R. Laser hair removal. J Drugs Dermatol 2006 July; 5(7).

 

Alexiades-Armenakas, M.R. Rhytides, laxity, and photodamage treated with a combination of radiofrequency, diode laser, and pulsed light and assessed with a comprehensive grading scale. J Drugs Dermatol 2006 Sep; 5 (8): 731-8.

 

Alexiades-Armenakas, M.R. A quantitative and comprehensive grading scale for rhytides, laxity and photoaging. J Drugs Dermatol 2006 Sep; 5 (8): 808-9.

 

Alexiades-Armenakas, M.R. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers. Dermatology Clinics 2007; 25: 25-33.

 

Alexiades-Armenakas, M. Laser and light-based treatment of cellulite. J Drugs Dermatol 2007 Jan; 6 (1): 83-4.

 

Alexiades-Armenakas M. What is new in lasers and cosmetic procedures from the 2007 AAD annual meeting. J Drugs Dermatol 2007 Jan; 6(4):464.

 

Alexiades-Armenakas M. Topical photodynamic therapy for the treatment of acne. Private Hospital Healthcare Europe, Camden Publishing, England 2007.

 

Alexiades-Armenakas M. Fractional laser resurfacing. J Drugs Dermatol 2007 Jul; 6(7): 750-1.

 

Alexiades-Armenakas M.R. The aesthetic. J Drugs Dermatol 2007 Nov; 6(11): 1082.

 

Alexiades-Armenakas M. R. Non-ablative Skin Tightening with a Variable Depth Heating 1,310 nm Wavelength Laser in Combination with Surface Cooling. J Drugs Dermatol 2007 Nov; 6 (11): 1098-1103.

 

Alexiades-Armenakas M.R. Nanotechnology. J Drugs Dermatol 2007 Nov; 6(11): 1155-6.

 

Alexiades-Armenakas M. Parabens toxicity to skin and other organs. J Drugs Dermatol Jan 2008; 7 (1): 77-78.

 

Alexiades-Armenakas M. Somatic stem cells in dermatology. J Drugs Dermatol March 2008.

 

Alexiades-Armenakas M.R., Dover J.S., Arndt K.A. The spectrum of laser resurfacing: non-ablative, fractional and ablative laser resurfacing. J Amer Acad Dermatol 2008 May; 58(5): 719-740.

 

Alexiades-Armenakas M.R. Dover J.S., Arndt K.A. Unipolar radiofrequency treatment to improve the appearance of cellulite. J Cosmetic Laser Therapy 2008; 10 (3): 148-53.

 

Alexiades-Armenakas M.R. Dover J.S., Arndt K.A. Unipolar vs. bipolar radiofrequency treatment of rhytides and laxity using a mobile painless delivery method. Lasers Surg Med 2008; 40(7): 446-453.


Alexiades-Armenakas M.R. Retrograde transport and transcytosis of botulinum toxin serotypes to the brain: analysis of potential neurotoxicity. J Drugs Dermatol Oct 2008; 7 (10).

 

Gotkin RH, Sarnoff DS, Cannarozzo G, Sadick NS, Alexiades-Armenakas M. Ablative skin resurfacing with a novel microablative CO2 laser. J Drugs Dermatol. 2009 Feb;8(2):138-44.

 

Alexiades-Armenakas M.R. Assessment of the mobile delivery of infrared light (1100-1800 nm) for the treatment of facial and neck skin laxity.J Drugs Dermatol 2009 Mar 8(3): 221-6.

 

Alexiades-Armenakas M.R. Safety of dermal fillers.  J Drugs Dermatol 2009 Mar 8(3):214-5.

 

Alexiades-Armenakas M, Willey A, Kilmer S, Goldberg D, Garden J, Berman D, Stridde B, Hantash BM, Renton B, Newman J. Prospective open-label multicenter clinical trial evaluating the efficacy of fractional radiofrequency for the treatment of facial rhytids and laxity. Las Surg Med, 42:33a, 2010.

           

Alexiades-Armenakas M. Sunscreen use in photodynamic therapy protocols. Derm Surg. In Press.

 

Alexiades-Armenakas, M., Rosenberg, D., Renton, B., Dover, J., Arndt, K.  Blinded, randomized quantitative grading comparison of minimally-invasive fractional radiofrequency and surgical facelift for the treatment of skin laxity. Arch Dermatol. 2010 Apr;146(4):396-405.

 

Alexiades-Armenakas M, Sarnoff D, Gotkin R, Sadick N. Multi-Center Clinical Study and Review of Fractional Ablative CO2 Laser Resurfacing for the Treatment of Rhytides, Photoaging, Scars and Striae. J Drugs Dermatol 2011 Apr;10(4):352-362

 

Alexiades-Armenakas, M. Aging Facial Skin: Broad-Band Light Technologies. Facial Plast Surg Clin North Am. 2011 May;19(2):361-70.

 

Alexiades-Armenakas, M. Combination Laser-Assisted Liposuction and Minimally-Invasive Skin Tightening with Temperature Feedback for Treatment of the Submentum and Neck. Dermatol Surg 2012;38:871–881,

 

Alexiades-Armenakas, M. Fractional Laser Resurfacing to Enhance Skin Permeation. Dermatol Surg 2012 Aug;38(8):1294-5.

 

Luebberding, S. and Alexiades-Armenakas, M. Safety of dermal fillers. J Drugs Dermatol September 2012 Sep; 11(9): 1053-8..

 

Luebberding, S. and Alexiades-Armenakas, M. Fractional non-ablative Q-switched Nd:YAG (1064 nm) laser treatment of skin aging: a pilot study. J Drugs Dermatol November 2012 Nov; 11(11):1300-4.

 

Alexiades-Armenakas M. Melanoma-detecting technologies and standard of care. J Drugs Dermatol 2012 Nov;11(11):1270-1.

 

Alexiades-Armenakas, M., Dover, J., Arndt, K. Fractional laser resurfacing. J Drugs Dermatol 2012 Nov; 11(11): 1274-87.

 

Alexiades-Armenakas M, Newman J, Willey A, Kilmer S, Goldberg D, Garden J, Berman D, Stridde B, Renton B, Berube D, Hantash B. Prospective Multicenter Clinical Trial of a Minimally-Invasive Temperature-Controlled Bipolar Fractional Radiofrequency System for Rhytid and Laxity Treatment. Derm Surg 2013 Feb;39(2):263-73.

 

Alexiades-Armenakas M, Nonablative skin resurfacing for skin rejuvenation. Up To Date 2013, J Dover and A Ofori Eds. Wolters Kluwer Health.

http://www.uptodate.com/contents/nonablative-skin-resurfacing-for-skin-rejuvenation

 

Armenakas, S, and Alexiades-Armenakas, M. Genetically-modified organisms in United States agriculture: mandate for food labeling. Food and Nutrition Sciences, Vol. 4 No. 8, 2013, pp. 807-811. doi: 10.4236/fns.2013.48105.

 

Luebberding, S. and Alexiades-Armenakas, M. Clinical appraisal of safety of dermal fillers. Current Reports, Elsevier 2013.

 

Narurkar, V., Alexiades-Armenakas M, Bank D, Weinkle S. Cosmetic Injectibles: Emerging Uses, Techniques, and Data. Practical Dermatology July 2013.

 

Krueger N, Luebberding S, Sattler G, Hanke CW, Alexiades-Armenakas M, Sadick N.

The history of aesthetic medicine and surgery. J Drugs Dermatol. 2013 Jul 1;12(7):737-42.

 

Xin F, Li-hong L, Alexiades-Armenakas M, Luebberding S, Cui-ping S, Yue H, Yu-xi A, Dan-xia Y, Rong-ya Y. Histological and electron microscopic analysis of fractional micro-plasma radio-frequency technology effects. J Drugs Dermatol. 2013 Nov;12(11):1210-4.

 

Alexiades-Armenakas M. Combination of light and energy-based technologies with topical drug delivery. J Drugs Dermatol. 2013 Nov;12(11):1208.

 

Alexiades-Armenakas M. Excel V roundtable. J Drugs Dermatol. 2013 Nov;12(11):1231-4. No abstract available.

 

Luebberding S, Alexiades-Armenakas M. New tattoo approaches in dermatology.

Dermatol Clin. 2014 Jan;32(1):91-6. doi: 10.1016/j.det.2013.09.002.

 

Luebberding S, Alexiades-Armenakas M. Facial volume augmentation in 2014: overview of different filler options. J Drugs Dermatol. 2013 Dec;12(12):1339-44.

 

Sadick NS, Nassar AH, Dorizas AS, Alexiades-Armenakas M.

Bipolar and multipolar radiofrequency.Dermatol Surg. 2014 Dec;40 Suppl 12:S174-9. doi:

 

Alexiades-Armenakas M. Commentary on photodynamic therapy of actinic cheilitis. Dermatol Surg. 2015 Feb;41(2):199-200.

 

Alexiades M, Berube D. Randomized, blinded, 3-arm clinical trial assessing optimal temperature and duration for treatment with minimally invasive fractional radiofrequency. Dermatol Surg. 2015 May;41(5):623-32. 

 

Alexiades, M. A Practical Guide: Equipment and Tools for Starting a Practice. Next Steps in Derm. Sanova Works, 2015.

 

Alexiades M. Randomized, double-blind, split-face study evaluating fractional ablative Erbium:YAG laser-mediated trans-epidermal delivery of cosmetic actives and a novel acoustic pressure wave ultrasound technology for the treatment of skin aging, melasma, and acne scars. J Drugs Dermatol. 2015 Nov;14(11):1191-8.

 

Alexiades, M. Wave science in dermatologic therapy. J Drugs Dermatol. 2015 Nov;14(11):1190.

 

Alexiades M. Jasmonates and Tetrahydrojasmonic Acid: A Novel Class of Anti-Aging Molecules. J Drugs Dermatol. 2016 Feb 1;15(2):206-7.

 

Alexiades M. Clinical Assessment of a Novel Jasmonate Cosmeceutical, LR2412-Cx, for the Treatment of Skin Aging. J Drugs Dermatol. 2016 Feb 1;15(2):209-15.

 

© Copyright NY Derm, LLC

Notice of privacy practices

  • Instagram Social Icon
  • Facebook Social Icon
  • Pinterest Social Icon
  • Twitter Social Icon